Acitretin: all 25 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Systemic Treatment Options for Generalized Lichen PlanusNot yet recruitingNCT06739551Phase 2
- Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and SolesTerminatedNCT02181790Phase 4Results posted
- A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced MelanomaTerminatedNCT02050321Phase 2Results posted
- Acitretin or Tazarotene Gel and Excimer Laser for Treatment of PsoriasisTerminatedNCT01094717Not applicableResults posted
- Alzheimer's Disease Acitretin MedicationCompletedNCT01078168Phase 2Results posted
- Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe PsoriasisCompletedNCT00936065Phase 4Results posted
- Acitretin and Etanercept in PsoriasisCompletedNCT00156247Phase 2Results posted
- Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .Status unknownNCT05401006Phase 4
- Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus AcitretinCompletedNCT05203354Phase 4
- Plexin B2 Gene Expression and Polymorphisms in PsoriasisCompletedNCT05184348Phase 1
- Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo RepigmentationStatus unknownNCT04245319Not applicable
- RA Effect on Cell Surface Molecules in VivoWithdrawnNCT03753867Phase 1
- Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin CapsulesStatus unknownNCT02715960Phase 2
- Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand DermatitisCompletedNCT01545284Phase 2/3
- Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2Status unknownNCT01443338Phase 4
- Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)WithdrawnNCT01299220Phase 4
- Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?Status unknownNCT01228409Phase 4
- Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type PsoriasisCompletedNCT01039142Phase 4
- Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawnNCT00832364Phase 4
- Evaluation of the Efficacy of Acitretin Therapy for Nail PsoriasisCompletedNCT00723437Phase 4
- Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque PsoriasisStatus unknownNCT00707070Phase 4
- Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin CancerCompletedNCT00644384Not applicable
- Acitretin Plasma Levels Under HemodialysisWithdrawnNCT00488384Phase 4
- Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ TransplantationCompletedNCT00003611Not applicable
- Treatment of Psoriasis Using Acitretin in HIV-Positive PatientsCompletedNCT00002143Phase 3